The NaPi2b transporter has been proposed as a cancer biomarker [5,10,11], as high levels of NaPi2b have been detected in cells of ovarian, lung, and thyroid carcinomas, as well as in several other malignant neoplasms [7,12,13,14,15,16,17,18,19]. Here, SLC34A2 is linked to cancer.